Quick Answer
STRATA Skin Sciences, Inc. reported Long Term Debt of $0.00 for the year ending 2025.
- STRATA Skin Sciences, Inc. showed a decrease of -100.0% in Long Term Debt from 2024 to 2025.
- This data is from STRATA Skin Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $11.34 million | Q2 2016: $11.35 million | Q3 2016: $10.55 million | Q1 2019: $6.42 million | Q2 2019: $5.70 million | Q3 2019: $4.98 million | Q2 2020: $1.73 million | Q3 2020: $1.39 million | Q1 2021: $717.0 thousand | Q2 2021: $497.0 thousand | Q3 2021: $7.28 million | Q1 2022: $7.36 million | Q2 2022: $7.40 million | Q3 2022: $7.44 million | Q1 2023: $7.52 million | Q2 2023: $14.99 million | Q3 2023: $15.02 million | Q1 2024: $15.08 million | Q2 2024: $15.11 million | Q3 2024: $15.15 million | Q1 2025: $15.23 million | Q2 2025: $15.27 million | Q3 2025: $13.44 million.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $15.19 million | Fiscal year 2023: $15.04 million | Fiscal year 2022: $7.48 million | Fiscal year 2021: $7.32 million | Fiscal year 2020: $1.05 million | Fiscal year 2019: $0.00 | Fiscal year 2018: $7.15 million | Fiscal year 2018: $7.36 million | Fiscal year 2018: $7.32 million | Fiscal year 2018: $6.87 million | Fiscal year 2017: $7.85 million | Fiscal year 2017: $8.84 million | Fiscal year 2017: $8.15 million | Fiscal year 2017: $8.95 million | Fiscal year 2016: $9.75 million | Fiscal year 2015: $9.85 million | Fiscal year 2014: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: